Nouveautés et nouveaux développements en matière de rétine et de technologie

Mon statut pour la session

Quand:
10:45, Dimanche 3 Juin 2018 (1 heure 35 minutes)
Pauses:
Dîner   12:15 PM à 01:30 PM (1 heure 15 minutes)
Où:
Metro Toronto Convention Centre (Édifice Sud) - Salle 803
Thème:
Rétine
OBJECTIFS D'APPRENTISSAGE
À la fin de la session, les participants pourront :
  • Intégrer l’évaluation de la non-perfusion maculaire et rétinienne dans l’évaluation clinique des patients atteints de rétinopathie diabétique. 
  • Décrire les progrès récents de l’interprétation et l’analyse de l’angiographie par TOC. 
  • Évaluer l’utilité clinique de nouveaux modes d’administration du médicament en pharmacothérapie intravitréenne. 
RÔLES CANMEDS : Expert médical, Leader

Usha Chakravarthy MD, PhD
Participant.e

Arif Samad
Modérateur.rice

Amin Kherani MD
Modérateur.rice

Sous sessions

Introduction
10:45 - 10:50 | 5 minutes
Changing the paradigm of retinal treatment through drug delivery
11:05 - 11:15 | 10 minutes

Authors: Varun Chaudhary, Ben Muirhead, Heather Sheardown Author Disclosure Block: V. Chaudhary: Grant/research support; Novartis, Bayer, Allergan. Employment/honoraria/consulting fees; Novartis, Bayer. Membership on an advisory panel, standing committee or board of directors; Novartis, Bayer. B. Muirhead: None. H. Sheardown: None. Abstract Body: Purpose: To assess three novel drug delivery vehicles for therapeutic retinal injections....

Varun Chaudhary
Participant.e
The diagnostic utility of multifocal electroretinography in detecting chloroquine and hydroxychloroquine retinal toxicity
11:30 - 11:40 | 10 minutes

Authors: Adrian C. Tsang, Sina Ahmadi, John Hamilton, Jennifer Gao, Gianni Virgili, Stuart Coupland, Chloe Gottlieb Author Disclosure Block: A.C. Tsang: None. S. Ahmadi: None. J. Hamilton: None. J. Gao: None. G. Virgili: None. S. Coupland: None. C. Gottlieb: None. Abstract Body: Purpose: To evaluate the diagnostic accuracy of the multifocal electroretinogram (mfERG) as a screening test for detecting hydroxychloroquine (HCQ) and chloroquin...

Adrian C. Tsang MD
Participant.e
Changes in aqueous cytokine levels following treatment with aflibercept in treatment naïve patients with diabetic macular edema
11:40 - 11:50 | 10 minutes

Author Block: Michael Y. Mak, Verena Juncal, Rajeev Muni Author Disclosure Block: M.Y. Mak: None. V. Juncal: None. R. Muni: Grant/research support; Research funding support, Bayer Inc., Research funding support, Novartis. Employment/honoraria/consulting fees; Speaking Honorarium, Bayer Inc., Speaking Honorarium, Novartis. Abstract Body: Purpose: To determine changes in aqueous cytokine levels in treatment- naive DME patients during intrav...

Michael Y. Mak MD
Participant.e
Macular buckle without vitrectomy for myopic macular schisis - A Canadian case series
11:50 - 12:00 | 10 minutes

Authors: Parampal Grewal, Steven Lapere, Rishi R. Gupta, Mark Greve Author Disclosure Block: P. Grewal: None. S. Lapere: None. R.R. Gupta: None. M. Greve: None. Abstract Body: Purpose: To determine the effectiveness of a macular buckle procedure without vitrectomy for myopic macular schisis. Study Design: Retrospective case series. Methods: All patients who underwent macular buckle surgery without ...

Parampal Grewal MD
Participant.e

Mon statut pour la session

Évaluer